Impact of beta ‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease
ConclusionsBeta-blockers reduced the all-cause mortality of patients with HFrEF and COPD after adjusting for age and heart rate, although the possibility of selection bias could not be completely excluded due to multinational prospective registry.
Source: ESC Heart Failure - Category: Cardiology Authors: Yoshiaki Kubota,
Wan Ting Tay,
Tiew ‐Hwa Katherine Teng,
Kuniya Asai,
Takashi Noda,
Kengo Kusano,
Atsushi Suzuki,
Nobuhisa Hagiwara,
Shinji Hisatake,
Takanori Ikeda,
Ryobun Yasuoka,
Takashi Kurita,
Wataru Shimizu,
ASIAN‐HF Executive Commi Tags: Original Research Article Source Type: research
More News: Beta-Blockers | Cardiology | Cardiovascular | Chronic Obstructive Pulmonary | Heart | Heart Failure | Japan Health